Results May Vary: Individual results will vary based on factors including age, baseline weight and metabolic health, diet quality, exercise habits, sleep patterns, stress levels, gut microbiome composition, genetic factors, current medications, consistency of use, and other individual variables
The data showed that once-weekly 1 mg doses of semaglutide were shown to reduce the likelihood of a first-time heart failure event, urgent visits or hospitalizations due to heart failure, or cardiovascular death
The minimum amount of protein to prevent muscle loss is 0.8 grams per kilogram per day
[PubMed] Compound 4: TB-500 Research Findings Cellular G-actin sequestration, cytoskeletal remodeling, keratinocyte and endothelial cell migration in Boyden chamber and scratch-wound assays Molecular Integrin-linked kinase (ILK) signaling, PINCH protein interactions, NF-B pathway modulation, MMP-2/MMP-9 expression in cultured fibroblasts and keratinocytes Systemic (Preclinical) Rodent models of dermal wound repair (normal, aged, and db/db diabetic), corneal injury, and cardiac ischemia-reperfusion using full-length TB4 with parallel fragment studies References (TB-500): Malinda KM, et al
Ivm Health currently offers multiple options including brand name Wegovy, Zepbound, Wegovy Pill, as well as compounded semaglutide and compounded tirzepatide as injectable options with individualized dosing and ongoing support from your care team
